{"id":133869,"date":"2026-08-08T19:37:09","date_gmt":"2026-08-08T19:37:09","guid":{"rendered":"https:\/\/www.europesays.com\/ai\/133869\/"},"modified":"2026-08-08T19:37:09","modified_gmt":"2026-08-08T19:37:09","slug":"actava-named-an-openai-select-partner","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ai\/133869\/","title":{"rendered":"actAVA Named an OpenAI Select Partner"},"content":{"rendered":"<p>    <a href=\"https:\/\/img.einpresswire.com\/large\/1167338\/8-8.png#536x302\" target=\"_blank\" rel=\"nofollow noopener\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.europesays.com\/ai\/wp-content\/uploads\/2026\/08\/8-8.png\" width=\"300\" height=\"169\" style=\"max-width: 100%; height: auto;\"\/><\/a><\/p>\n<p>actAVA x OpenAI<\/p>\n<p style=\"margin-bottom:1em;font-size:115%;\">Healthcare workflow-to-model learning platform joins the OpenAI Partner Network to help health systems move AI from pilot to production, safely and at scale<\/p>\n<p>CA, UNITED STATES, August 8, 2026 \/<a href=\"https:\/\/www.einpresswire.com\/\" dir=\"auto\" rel=\"nofollow external noopener\" target=\"_blank\">EINPresswire.com<\/a>\/ &#8212; actAVA, a healthcare workflow-to-model learning platform, today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network.<\/p>\n<p>The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships, while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact.<\/p>\n<p>As an OpenAI Select Partner, actAVA will continue working with OpenAI to help healthcare organizations build, deploy, and scale AI solutions responsibly. Through its KORA platform, actAVA combines frontier model capabilities with the governance, testing, and audit controls required in regulated healthcare environments.<\/p>\n<p>Through its KORA platform, actAVA wraps that frontier capability in the governance, testing, and audit rigor required by regulated healthcare environments. This enables health systems to put agentic AI to work across prior authorization, utilization management, care management, and other high-stakes administrative workflows.<\/p>\n<p>\u201cFrontier models are advancing rapidly, and healthcare organizations need a safe, practical path to put them to work,\u201d said Kevin Riley, Co-Founder and CEO of actAVA. \u201cBeing named an OpenAI Select Partner allows us to pair OpenAI\u2019s models with the guardrails clinical operations require, helping health systems move AI from pilot to production with stronger governance, auditability, and cost control.\u201d<\/p>\n<p>actAVA supports payers, providers, and health systems across four KORA capabilities: Plan &amp; Build, Test &amp; Measure, Optimize &amp; Scale, and Govern &amp; Audit.<br \/>&#13;<br \/>\nThe company\u2019s work includes:<br \/>&#13;<br \/>\n\uf0b7Publishing \u03c7-Bench, the world\u2019s first long-horizon healthcare benchmark for AI agents, developed with more than 20 hospitals and universities<br \/>&#13;<br \/>\n\uf0b7Delivering CHRYSO, a compliance solution that automates requirements across the NIST AI Risk Management Framework, HIPAA, and CMS standards<br \/>&#13;<br \/>\n\uf0b7Collaborating with leading institutions, including Johns Hopkins Medicine<\/p>\n<p>actAVA is HIPAA compliant and SOC 2 certified. Its platform enables teams to build and manage agents using private or anonymized models from leading AI providers.<br \/>&#13;<br \/>\nLooking ahead, actAVA plans to deepen its OpenAI-related offerings, including expanding model coverage within KORA. The company will continue investing in enablement for healthcare teams, scaling customer deployments, and helping customers translate AI ambition into measurable business and patient outcomes.<\/p>\n<p>Learn more about the OpenAI Partner Network at openai.com\/business\/partners.<br \/>&#13;<br \/>\nAbout actAVA<br \/>&#13;<br \/>\nactAVA is the workflow-to-model learning platform for healthcare\u2019s operational long tail: those document-heavy, rules-driven, cross-system use cases that single-purpose software cannot economically serve, and that you want to own.<br \/>&#13;<br \/>\nContact: sales@actava.ai<\/p>\n<p class=\"contact\" dir=\"auto\" style=\"margin: 1em 0;\">Shunxin Pang<br \/>HashMatrix<br \/>+1 416-605-0175<br \/><a href=\"http:\/\/www.einpresswire.com\/contact_author\/932713289\" data-src=\"mVQrogAM6aRr3aeY\" rel=\"nofollow noopener\" target=\"_blank\">email us here<\/a><br \/>Visit us on social media:<br \/><a href=\"https:\/\/www.linkedin.com\/company\/actava\" rel=\"nofollow noopener\" target=\"_blank\">LinkedIn<\/a><br \/><a href=\"https:\/\/x.com\/actAVAai\" rel=\"nofollow\">X<\/a><\/p>\n<p>\n    Legal Disclaimer:\n  <\/p>\n<p>\n    EIN Presswire provides this news content &#8220;as is&#8221; without warranty of any kind. We do not accept any responsibility or liability<br \/>\n    for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this<br \/>\n    article. If you have any complaints or copyright issues related to this article, kindly contact the author above.\n  <\/p>\n<p>    <img decoding=\"async\" alt=\"\" class=\"prtr\" src=\"https:\/\/www.europesays.com\/ai\/wp-content\/uploads\/2026\/08\/1786217829_663_article.gif\"\/><\/p>\n<p class=\"text-center\">You just read:<\/p>\n<p>News Provided By<\/p>\n<p>\n      August 08, 2026, 19:07 GMT\n    <\/p>\n<p>\n        <br \/>EIN Presswire&#8217;s priority is author transparency. We do our best to weed out false and misleading content. The content above is<br \/>\nthe sole responsibility of the author who makes it available. If you have any complaints, kindly contact the author above.\n      <\/p>\n","protected":false},"excerpt":{"rendered":"actAVA x OpenAI Healthcare workflow-to-model learning platform joins the OpenAI Partner Network to help health systems move AI&hellip;\n","protected":false},"author":2,"featured_media":133870,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[7685,66499,9172,56502,157,66500],"class_list":["post-133869","post","type-post","status-publish","format-standard","has-post-thumbnail","category-openai","tag-partner","tag-actava","tag-an","tag-named","tag-openai","tag-select"],"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/posts\/133869","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/comments?post=133869"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/posts\/133869\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/media\/133870"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/media?parent=133869"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/categories?post=133869"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ai\/wp-json\/wp\/v2\/tags?post=133869"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}